KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Rigel Pharmaceuticals (RIGL) over the last 17 years, with Q3 2025 value amounting to -$3.4 million.

  • Rigel Pharmaceuticals' Change in Account Payables fell 4876.89% to -$3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31000.0, marking a year-over-year increase of 10074.09%. This contributed to the annual value of -$3.8 million for FY2024, which is 93907.1% down from last year.
  • Rigel Pharmaceuticals' Change in Account Payables amounted to -$3.4 million in Q3 2025, which was down 4876.89% from $3.3 million recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Change in Account Payables registered a high of $4.8 million during Q4 2022, and its lowest value of -$3.4 million during Q3 2025.
  • Moreover, its 5-year median value for Change in Account Payables was $586000.0 (2022), whereas its average is $8789.5.
  • Per our database at Business Quant, Rigel Pharmaceuticals' Change in Account Payables tumbled by 38367.85% in 2021 and then skyrocketed by 58680.06% in 2022.
  • Over the past 5 years, Rigel Pharmaceuticals' Change in Account Payables (Quarter) stood at $697000.0 in 2021, then soared by 586.8% to $4.8 million in 2022, then tumbled by 117.9% to -$857000.0 in 2023, then soared by 44.46% to -$476000.0 in 2024, then crashed by 623.53% to -$3.4 million in 2025.
  • Its Change in Account Payables stands at -$3.4 million for Q3 2025, versus $3.3 million for Q2 2025 and $615000.0 for Q1 2025.